Pfizer spikes on impressive Q2FY18 earnings
DSIJ Intelligence / 10 Nov 2017
In terms of the bottom-line, the company reported a PAT figure of Rs. 111.15 crore which represents a sequential QoQ increase of 94.32 per cent and a YoY increase of 27.25 per cent.
Pfizer Limited (India) reported its results for the quarter ended September 30, 2017 during market hours on Friday.
Total sales for this quarter, Q2FY18, came in at Rs. 571.11 crore. This represents a 32.02 per cent sequential increase and 2.41 per cent YoY increase.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 167.22 crore and the EBIT margin stood at 29.28 per cent.
In terms of the bottom-line, the company reported a PAT figure of Rs. 111.15 crore which represents a sequential QoQ increase of 94.32 per cent and a YoY increase of 27.25 per cent.
The company's stock which opened for trading at Rs. 1764.5 on the BSE, has risen by 9 per cent after the results were declared and at 14:54 trading at Rs. 1915.1 mark.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.